Skip Navigation Menu
Government of Ontario Central Web Site Ontario Ministry of Health and Long-Term Care
Return to Home Page Government of Ontario Central Web Site Contact us for questions and comments Site map Version française de cette site web
Information Channels Public Information Health Care Providers News Media Text Only Version
Index Health Care Provider Section
Formulary Downloads
O P D P   H O M E
Plan to Reform Ontario’s Drug System
Legislation
Formulary
Publicly Funded Drug Programs
Executive Officer Communications
Drug Submissions
· Ontario Guidelines for Drug
  Submission and Evaluation

· Drug Submission Status
· Improving Patient Access to
  Drugs: Rapid Review Process

· Single Monthly Formulary
  Process

·Off-Formulary Interchangeability
· Ontario Guidelines for Economic
  Analysis of Pharmaceutical
  Products

· Submission Guidelines for
  Oncology Drugs

· Inter-Provincial Joint
  Oncology Drug Review
  Process

· Submission Guidelines for
  Diabetic Testing Agents

· Submission Guidelines for
  Nutrition Products

· Guideline and Template
  Downloads
How Drugs Are Approved
Councils
Drug Innovation Fund
MedsCheck
Glossary
Forms/Guidelines
FAQs
Resources
Contact Us

Drug Submissions

Ontario Guidelines for Drug Submission and Evaluation

A drug product will be considered for listing and interchangeability designation in the Formulary where a pharmaceutical manufacturer has made a submission to the Ontario Ministry of Health and Long-Term Care. The submission must comply with the requirements specified in O. Reg. 201/96 under the Ontario Drug Benefit Act and Regulation 935 under the Drug Interchangeability and Dispensing Fee Act. Submissions must be properly prepared and formatted as indicated in Parts I and II of the interpretive guidelines.

The purpose of the interpretive guidelines is to assist pharmaceutical manufacturers in making their drug submissions. The guidelines include various template letters, checklists and worksheets for manufacturers to use in preparing their submissions to the ministry.

A .pdf copy of the Ontario Guidelines for Drug Submission and Evaluation is available for download or copies may also be purchased from Publications Ontario at 1-800-668-9938 or 416-326-5300.

Pharmaceutical manufacturers should refer to this web site for any future updates to the interpretive guidelines.

The Ministry is currently in the process of updating the Ontario Guidelines for Drug Submission and Evaluation to reflect and consolidate the regulatory and policy changes that have been implemented and communicated since September 2000. Note that the current Guidelines, prior to their amendment, may contain some inconsistencies with current legislation and regulations. Consult with the applicable legislation and regulations for the statement of the current law. In the event of any inconsistency between the Guidelines and the regulations and legislation, the regulations and legislation prevail.

See Also :

For more information
INFOline
Tel : 1-866-532-3161
(Toll-free in Ontario only)
TTY 1-800-387-5559
Hours of operation: 8:30am - 5:00pm
Go to top of page
|  home  |  central site  |  contact us  |  site map  |  français  |

This site maintained by the government of Ontario, Canada.